AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.92
+0.14
(+1.05%)
Pre-Market: 08:11
AbCellera Biologics Max Drawdown (5Y) : 96.72% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.72% |
| August 31, 2026 | 96.72% |
| July 31, 2026 | 96.72% |
| June 30, 2026 | 96.72% |
| May 31, 2026 | 96.72% |
| April 30, 2026 | 96.72% |
| March 31, 2026 | 96.72% |
| February 28, 2026 | 96.72% |
| January 31, 2026 | 96.72% |
| December 31, 2025 | 96.72% |
| November 30, 2025 | 96.72% |
| October 31, 2025 | 96.72% |
| September 30, 2025 | 96.72% |
| August 31, 2025 | 96.72% |
| July 31, 2025 | 96.72% |
| June 30, 2025 | 96.72% |
| May 31, 2025 | 96.72% |
| April 30, 2025 | 96.72% |
| March 31, 2025 | 96.26% |
| February 28, 2025 | 95.94% |
| January 31, 2025 | 95.94% |
| December 31, 2024 | 95.94% |
| November 30, 2024 | 95.94% |
| October 31, 2024 | 95.94% |
| September 30, 2024 | 95.94% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.74% |
| July 31, 2024 | 95.43% |
| June 30, 2024 | 95.36% |
| May 31, 2024 | 93.84% |
| April 30, 2024 | 93.84% |
| March 31, 2024 | 93.36% |
| February 29, 2024 | 93.36% |
| January 31, 2024 | 93.36% |
| December 31, 2023 | 93.36% |
| November 30, 2023 | 93.36% |
| October 31, 2023 | 93.36% |
| September 30, 2023 | 92.19% |
| August 31, 2023 | 90.75% |
| July 31, 2023 | 90.39% |
| June 30, 2023 | 90.39% |
| May 31, 2023 | 90.39% |
| April 30, 2023 | 90.29% |
| March 31, 2023 | 90.29% |
| February 28, 2023 | 90.29% |
| January 31, 2023 | 90.29% |
| December 31, 2022 | 90.29% |
| November 30, 2022 | 90.29% |
| October 31, 2022 | 90.29% |
| September 30, 2022 | 90.29% |
| August 31, 2022 | 90.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| MindWalk Holdings Corp. | 98.24% |
| Repligen Corp. | 68.27% |
| Bio-Techne Corp. | 67.22% |
| Aurinia Pharmaceuticals, Inc. | 87.58% |
| BioLife Solutions, Inc. | 85.14% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -24.00 |
| Beta (5Y) | 1.406 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.73% |
| Historical Sharpe Ratio (5Y) | -0.1246 |
| Historical Sortino (5Y) | -0.2931 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.71% |